JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.04% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
First Trust Capital Strength ETF
FTCS
$8.02B
| $3.07M | ﹤0.01% |
43,874
+27,207
| +163% | +$2M |
|
3052
Dime Commercial Bancshares
DCOM
$1.81B
| $3.07M | ﹤0.01% |
103,417
+9,007
| +10% | +$286K |
|
3053
Parsons
PSN
$5.16B
| $3.06M | ﹤0.01% |
75,769
+20,359
| +37% | +$780K |
|
3054
iShares Core 10+ Year USD Bond ETF
ILTB
$595M
| $3.06M | ﹤0.01% |
55,037
-6,233
| -10% | -$359K |
|
3055
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $3.06M | ﹤0.01% |
35,000
-586,000
| -94% | -$55.2M |
|
|
CCRN
3056
DELISTED
Cross Country Healthcare
CCRN
| $3.06M | ﹤0.01% |
146,738
-109,294
| -43% | -$2.05M |
|
3057
Cheesecake Factory
CAKE
$5.84B
| $3.06M | ﹤0.01% |
115,602
+48,366
| +72% | +$1.61M |
|
|
TRQ
3058
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $3.05M | ﹤0.01% |
114,013
+46,372
| +69% | +$1.31M |
|
3059
CALL
Edwards Lifesciences
EW
$53.6B
| $3.05M | ﹤0.01% |
32,100
-399,800
| -93% | -$41.4M |
|
|
FBMS
3060
DELISTED
The First Bancshares, Inc.
FBMS
| $3.05M | ﹤0.01% |
106,731
+41,319
| +63% | +$1.28M |
|
|
MNTV
3061
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $3.05M | ﹤0.01% |
346,309
-13,601
| -4% | -$182K |
|
3062
Ubiquiti
UI
$35B
| $3.05M | ﹤0.01% |
12,275
+207
| +2% | +$55.1K |
|
|
INFN
3063
DELISTED
Infinera Corporation Common Stock
INFN
| $3.05M | ﹤0.01% |
568,077
+87,120
| +18% | +$558K |
|
3064
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $3.04M | ﹤0.01% |
17,356
-18,493
| -52% | -$3.58M |
|
|
VIVO
3065
DELISTED
Meridian Bioscience Inc
VIVO
| $3.04M | ﹤0.01% |
100,032
-56,599
| -36% | -$1.53M |
|
3066
Capital City Bank Group
CCBG
$896M
| $3.04M | ﹤0.01% |
109,027
+87,929
| +417% | +$2.31M |
|
3067
Universal Corp
UVV
$1.13B
| $3.04M | ﹤0.01% |
50,234
-6,245
| -11% | -$372K |
|
3068
Vertiv
VRT
$111B
| $3.04M | ﹤0.01% |
369,713
+132,851
| +56% | +$1.5M |
|
|
KRTX
3069
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.03M | ﹤0.01% |
23,966
+3,748
| +19% | +$431K |
|
|
KLRS
3070
Kalaris Therapeutics
KLRS
$92.4M
| $3.03M | ﹤0.01% |
33,731
+518
| +2% | +$54.3K |
|
3071
PUT
Bilibili
BILI
$7.14B
| $3.02M | ﹤0.01% |
118,000
+40,000
| +51% | +$962K |
|
3072
Digi International
DGII
$3.23B
| $3.02M | ﹤0.01% |
124,702
-25,922
| -17% | -$562K |
|
|
DAWN
3073
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| $3.01M | ﹤0.01% |
+168,300
| New | +$1.74M |
|
3074
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$24.8B
| $3.01M | ﹤0.01% |
+229,715
| New | +$5.18M |
|
3075
PUT
Rivian
RIVN
$22.9B
| $3.01M | ﹤0.01% |
116,800
-100,000
| -46% | -$3.12M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.